1. Reversing Multidrug-Resistant by RNA Interference Through Silencing MDR1 Gene in Human Hepatocellular Carcinoma Cells Subline Bel-7402/ADM
    Long Sheng et al, 2014, Pathol. Oncol. Res. CrossRef
  2. Integrated analysis of differentially expressed mRNAs and miRNAs between hepatocellular carcinoma and their matched adjacent normal liver tissues
    BING GAO et al, 2015 CrossRef
  3. The polysaccharides from fermented Ganoderma lucidum mycelia induced miRNAs regulation in suppressed HepG2 cells
    Jie Shen et al, 2014, Carbohydrate Polymers CrossRef
  4. miR-27b is upregulated in cervical carcinogenesis and promotes cell growth and invasion by regulating CDH11 and epithelial-mesenchymal transition
    JIHANG YAO et al, 2016 CrossRef
  5. Expression and function of microRNA-27b in hepatocellular carcinoma.
    Shujie He et al, 2016, Mol Med Rep CrossRef
  6. Role of MTDH, FOXM1 and microRNAs in Drug Resistance in Hepatocellular Carcinoma
    Xiangbing Meng et al, 2014, Diseases CrossRef
  7. Promising therapeutic role of miR-27b in tumor
    Li Ding et al, 2017, Tumour Biol. CrossRef
  8. Interactions between anticancer active platinum complexes and non-coding RNAs/microRNAs
    Bernhard Biersack, 2017, Non-coding RNA Research CrossRef
  9. Non-coding RNA/microRNA-modulatory dietary factors and natural products for improved cancer therapy and prevention: Alkaloids, organosulfur compounds, aliphatic carboxylic acids and water-soluble vitamins
    Bernhard Biersack, 2016, Non-coding RNA Research CrossRef
  10. Downregulation of microRNA-27b-3p enhances tamoxifen resistance in breast cancer by increasing NR5A2 and CREB1 expression
    Jiang Zhu et al, 2016, Cell Death Dis CrossRef
  11. MiRNA expression profiles reveal the involvement of miR-26a, miR-548l and miR-34a in hepatocellular carcinoma progression through regulation of ST3GAL5
    Hongjiao Cai et al, 2017, Lab Invest CrossRef
  12. Systems biology of cisplatin resistance: past, present and future.
    L Galluzzi et al, 2014, Cell Death Dis CrossRef
  13. ABC Transporters: Regulation and Association with Multidrug Resistance in Hepatocellular Carcinoma and Colorectal Carcinoma
    María Paula Ceballos et al, 2019, CMC CrossRef
  14. miR-146a is directly regulated by STAT3 in human hepatocellular carcinoma cells and involved in anti-tumor immune suppression
    Xiaoxia Sun et al, 2015, Cell Cycle CrossRef
  15. 17-Demethoxy-reblastatin, an Hsp90 inhibitor, induces mitochondria-mediated apoptosis through downregulation of Mcl-1 in human hepatocellular carcinoma cells
    Surong Zhao et al, 2015, J Bioenerg Biomembr CrossRef
  16. Mechanisms of doxorubicin resistance in hepatocellular carcinoma
    Josiah Cox et al, 2016, Hepatic Oncology CrossRef
  17. Serum microRNA profiles as diagnostic biomarkers for HBV-positive hepatocellular carcinoma
    Hao-Tu Zhu et al, 2017, Liver Int CrossRef
  18. Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression
    Shuzhen Chang et al, 2017, BMC Cancer CrossRef
  19. null
    Baojun Duan et al, 2019 CrossRef
  20. RNA-seq reveals distinctive RNA profiles of small extracellular vesicles from different human liver cancer cell lines.
    Annalisa Radeghieri, 0 CrossRef
  21. The miR27b-CCNG1-P53-miR-508-5p axis regulates multidrug resistance of gastric cancer
    Yulong Shang et al, 2016, Oncotarget CrossRef
  22. Knockdown of long non‑coding RNA HOTAIR sensitizes hepatocellular carcinoma cell to cisplatin by suppressing the STAT3/ABCB1 signaling pathway
    Jia‑Jia Zhou et al, 2017, Oncol Lett CrossRef
  23. Multiple roles of microRNA‑146a in immune responses and hepatocellular carcinoma (Review)
    Huihui Wang et al, 2019, Oncol Lett CrossRef
  24. Exosome-Derived Circ-PVT1 Contributes to Cisplatin Resistance by Regulating Autophagy, Invasion, and Apoptosis Via miR-30a-5p/YAP1 Axis in Gastric Cancer Cells.
    Wenjuan Yao et al, 2021, Cancer Biother Radiopharm CrossRef
  25. Reduced Expression of miRNA-27a Modulates Cisplatin Resistance in Bladder Cancer by Targeting the Cystine/Glutamate Exchanger SLC7A11
    Ross M. Drayton et al, 2014, Clin Cancer Res CrossRef
  26. Circ_0031242 Silencing Mitigates the Progression and Drug Resistance in DDP-Resistant Hepatoma Cells by the miR-924/POU3F2 Axis
    Wei Fan et al, 2021, CMAR CrossRef
  27. microRNA-27b regulates hepatic lipase enzyme LIPC and reduces triglyceride degradation during hepatitis C virus infection
    Geneviève.F. Desrochers et al, 2022, Journal of Biological Chemistry CrossRef
  28. Oncogenic microRNA-181d binding to OGT contributes to resistance of ovarian cancer cells to cisplatin
    Wei Huang et al, 2021, Cell Death Discov. CrossRef
  29. miR-9 and miR-181a Target Gab2 to Inhibit the Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells
    Lantang Huang et al, 2022, Genes CrossRef
  30. Potential Phytochemicals for Prevention of Familial Breast Cancer with BRCA Mutations
    Aliasgar Fakruddin Shahiwala et al, 2023, CDT CrossRef
  31. Combating drug resistance in hepatocellular carcinoma: No awareness today, no action tomorrow
    Fanbo Jing et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  32. Non-coding RNA transcripts, incredible modulators of cisplatin chemo-resistance in bladder cancer through operating a broad spectrum of cellular processes and signaling mechanism
    Mehrdad Hashem et al, 2024, Non-coding RNA Research CrossRef
  33. Expression and effect of miR‑27b in primary liver cancer
    Lijuan Zhuo et al, 2023, Oncol Lett CrossRef
  34. The Role of microRNAs in Hepatocellular Cancer: A Narrative Review Focused on Tumor Microenvironment and Drug Resistance
    Ali Tavakoli Pirzaman et al, 2024, Technol Cancer Res Treat CrossRef